{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:08:54Z","timestamp":1791407334372,"version":"4.3.3"},"reference-count":84,"publisher":"Wiley","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1517,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1111\/j.1742-1241.2011.02726.x","type":"journal-article","created":{"date-parts":[[2011,7,7]],"date-time":"2011-07-07T12:12:05Z","timestamp":1310040725000},"page":"35-43","source":"Crossref","is-referenced-by-count":10,"special_numbering":"supplement s172","title":["Transforming growth factor signalling: a common pathway in pulmonary arterial hypertension and systemic sclerosis"],"prefix":"10.1155","volume":"65","author":[{"given":"N.","family":"Hatton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Frech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sawitzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. B.","family":"Scholand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Markewitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,7,7]]},"reference":[{"issue":"Suppl. 1","key":"10.1111\/j.1742-1241.2011.02726.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","article-title":"Updated clinical classification of pulmonary hypertension","volume":"54","author":"Simonneau","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","article-title":"ACCF\/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association","volume":"53","author":"McLaughlin","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1378\/chest.104.1.236","article-title":"Primary pulmonary hypertension","volume":"104","author":"Rubin","year":"1993","journal-title":"Chest"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension. Results from a national prospective registry","volume":"115","author":"D\u2019Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/eurheartj\/ehl477","article-title":"Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension","volume":"28","author":"van Wolferen","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra035488","article-title":"Pulmonary arterial hypertension","volume":"351","author":"Farber","year":"2004","journal-title":"N Engl J Med"},{"issue":"12 Suppl. S","key":"10.1111\/j.1742-1241.2011.02726.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"25S","DOI":"10.1016\/j.jacc.2004.02.033","article-title":"Pathologic assessment of vasculopathies in pulmonary hypertension","volume":"43","author":"Pietra","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0046-8177(95)90088-8","article-title":"Different distribution of plexiform lesions in primary and secondary pulmonary hypertension","volume":"26","author":"Jamison","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1183\/09031936.00106008","article-title":"Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive vasculopathy","volume":"34","author":"Overbeek","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/ard.62.11.1088","article-title":"Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach","volume":"62","author":"Mukerjee","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1002\/art.21433","article-title":"Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study","volume":"52","author":"Hachulla","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB12|cit12","first-page":"139","article-title":"Mortality in systemic sclerosis (scleroderma)","volume":"82","author":"Lee","year":"1992","journal-title":"Q J Med"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/rheumatology\/ken488","article-title":"Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinerAIR-Sclerodermie study","volume":"48","author":"Hachulla","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl. 1","key":"10.1111\/j.1742-1241.2011.02726.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"14S","DOI":"10.1378\/chest.126.1_suppl.14S","article-title":"Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines","volume":"126","author":"McGoon","year":"2004","journal-title":"Chest"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1378\/chest.09-1140","article-title":"Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry","volume":"137","author":"Badesch","year":"2010","journal-title":"Chest"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7326\/0003-4819-107-2-216","article-title":"Primary pulmonary hypertension. A national prospective study","volume":"107","author":"Rich","year":"1987","journal-title":"Ann Intern Med"},{"issue":"12 Suppl. S","key":"10.1111\/j.1742-1241.2011.02726.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/j.jacc.2004.02.029","article-title":"Cellular and molecular pathobiology of pulmonary arterial hypertension","volume":"43","author":"Humbert","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1164\/rccm.200712-1807OC","article-title":"Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation","volume":"177","author":"Sztrymf","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/303059","article-title":"Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene","volume":"67","author":"Deng","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/79226","article-title":"Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension","volume":"26","author":"Lane","year":"2000","journal-title":"Nat Genet"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJM200108023450503","article-title":"Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia","volume":"345","author":"Trembath","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.blre.2010.07.001","article-title":"Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment","volume":"24","author":"Shovlin","year":"2010","journal-title":"Blood Rev"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1164\/rccm.200602-165OC","article-title":"High frequency of BMPR2 exonic deletions\/duplications in familial pulmonary arterial hypertension","volume":"174","author":"Cogan","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/humu.9398","article-title":"BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension","volume":"27","author":"Aldred","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/jmg.37.10.741","article-title":"Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family","volume":"37","author":"Thomson","year":"2000","journal-title":"J Med Genet"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/humu.20285","article-title":"Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension","volume":"27","author":"Machado","year":"2006","journal-title":"Hum Mutat"},{"issue":"Suppl. 1","key":"10.1111\/j.1742-1241.2011.02726.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.jacc.2009.04.015","article-title":"Genetics and genomics of pulmonary arterial hypertension","volume":"54","author":"Machado","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199608293350901","article-title":"Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group","volume":"335","author":"Abenhaim","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1378\/chest.130.6.1657","article-title":"Is methamphetamine use associated with idiopathic pulmonary arterial hypertension?","volume":"130","author":"Chin","year":"2006","journal-title":"Chest"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0735-1097(83)80133-8","article-title":"An epidemic of pulmonary hypertension after toxic rapeseed oil ingestion in Spain","volume":"1","author":"Garcia-Dorado","year":"1983","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3109\/03009749009092627","article-title":"Scleroderma after therapy with appetite suppressants. Report on four cases","volume":"19","author":"Aeschlimann","year":"1990","journal-title":"Scand J Rheumatol"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jbspin.2007.04.005","article-title":"Genetic basis for systemic sclerosis","volume":"74","author":"Allanore","year":"2007","journal-title":"Joint Bone Spine"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB33|cit33","first-page":"41","article-title":"Geographical clustering of scleroderma in a rural area in the province of Rome","volume":"11","author":"Valesini","year":"1993","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB34|cit34","first-page":"79","volume-title":"Progressive Systemic Sclerosis (Current Topics in Rheumatology)","author":"Shinkai","year":"1985"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.semarthrit.2007.05.003","article-title":"Incidence and prevalence of systemic sclerosis: a systematic literature review","volume":"37","author":"Chifflot","year":"2008","journal-title":"Semin Arthritis Rheum"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/rheumatology\/29.2.92","article-title":"Geographical clustering of scleroderma in south and west London","volume":"29","author":"Silman","year":"1990","journal-title":"Br J Rheumatol"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1002\/art.11280","article-title":"Examination of the possible role of biologically relevant genes around FBN1 in systemic sclerosis in the Choctaw population","volume":"48","author":"Tan","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.21948","article-title":"Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts","volume":"54","author":"Wang","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.3899\/jrheum.090207","article-title":"Systemic sclerosis: environmental factors","volume":"36","author":"Mora","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1136\/oem.59.8.545","article-title":"Systemic sclerosis and occupational risk factors: a case-control study","volume":"59","author":"Diot","year":"2002","journal-title":"Occup Environ Med"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/aje\/kwf223","article-title":"Scleroderma and solvent exposure among women","volume":"157","author":"Garabrant","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/ard.51.12.1322","article-title":"What is the contribution of occupational environmental factors to the occurrence of scleroderma in men?","volume":"51","author":"Silman","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-140-2-200401200-00013","article-title":"Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis","volume":"140","author":"Jimenez","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S","article-title":"Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts","volume":"44","author":"Arnett","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1445-5994.1999.tb01586.x","article-title":"Familial risk estimation in systemic sclerosis","volume":"29","author":"Englert","year":"1999","journal-title":"Aust N Z J Med"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/art.27469","article-title":"Heritability of vasculopathy, autoimmune disease, and fibrosis in systemic sclerosis: a population-based study","volume":"62","author":"Frech","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1002\/art.11173","article-title":"Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies","volume":"48","author":"Feghali-Bostwick","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1002\/art.21355","article-title":"Monozygotic twins clinically discordant for scleroderma show concordance for fibroblast gene expression profiles","volume":"52","author":"Zhou","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa067655","article-title":"A polymorphism in the CTGF promoter region associated with systemic sclerosis","volume":"357","author":"Fonseca","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/1529-0131(200104)44:4<893::AID-ANR146>3.0.CO;2-3","article-title":"Association of fibrillin 1 single-nucleotide polymorphism haplotypes with systemic sclerosis in Choctaw and Japanese populations","volume":"44","author":"Tan","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/1529-0131(200108)44:8<1855::AID-ART324>3.0.CO;2-Q","article-title":"Abnormalities in fibrillin 1-containing microfibrils in dermal fibroblast cultures from patients with systemic sclerosis (scleroderma)","volume":"44","author":"Wallis","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng1116","article-title":"Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome","volume":"33","author":"Neptune","year":"2003","journal-title":"Nat Genet"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nrrheum.2009.26","article-title":"Transforming growth factor beta as a therapeutic target in systemic sclerosis","volume":"5","author":"Varga","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1002\/art.24688","article-title":"STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis","volume":"60","author":"Dieude","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB55|cit55","first-page":"2379","article-title":"Pulmonary hypertension in scleroderma spectrum of disease: lack of bone morphogenetic protein receptor 2 mutations","volume":"29","author":"Morse","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1002\/art.10487","article-title":"Mutations of bone morphogenetic protein receptor type II are not found in patients with pulmonary hypertension and underlying connective tissue diseases","volume":"46","author":"Tew","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s10067-006-0388-x","article-title":"Mutations of activin-receptor-like kinase 1 (ALK-1) are not found in patients with pulmonary hypertension and underlying connective tissue disease","volume":"26","author":"Selva-O\u2019Callaghan","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/jcb.21501","article-title":"TGF-beta signaling: a tale of two responses","volume":"102","author":"Rahimi","year":"2007","journal-title":"J Cell Biochem"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2249.2009.03944.x","article-title":"Interleukin-17 and systemic lupus erythematosus: current concepts","volume":"157","author":"Nalbandian","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/371257a0","article-title":"p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest","volume":"371","author":"Hannon","year":"1994","journal-title":"Nature"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/978-1-60761-869-0_21","article-title":"Transforming growth factor-beta: recent advances on its role in immune tolerance","volume":"677","author":"Mantel","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1146\/annurev.biochem.67.1.753","article-title":"TGF-beta signal transduction","volume":"67","author":"Massague","year":"1998","journal-title":"Annu Rev Biochem"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1083\/jcb.200204088","article-title":"TGF beta receptor internalization into EEA1-enriched early endosomes: role in signaling to Smad2","volume":"158","author":"Hayes","year":"2002","journal-title":"J Cell Biol"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1093\/carcin\/bgl068","article-title":"Escaping from the TGFbeta anti-proliferative control","volume":"27","author":"Seoane","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1101\/gad.1350705","article-title":"Smad transcription factors","volume":"19","author":"Massague","year":"2005","journal-title":"Genes Dev"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jdermsci.2007.05.014","article-title":"Autocrine TGF-beta signaling in the pathogenesis of systemic sclerosis","volume":"49","author":"Ihn","year":"2008","journal-title":"J Dermatol Sci"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11926-008-0030-9","article-title":"In perspective: murine models of scleroderma","volume":"10","author":"Wu","year":"2008","journal-title":"Curr Rheumatol Rep"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"12319","DOI":"10.1073\/pnas.1635114100","article-title":"Systemic and cell type-specific gene expression patterns in scleroderma skin","volume":"100","author":"Whitfield","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1002\/art.22063","article-title":"Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: A model of scleroderma","volume":"54","author":"Pannu","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/1529-0131(200103)44:3<731::AID-ANR124>3.0.CO;2-U","article-title":"Up-regulated expression of transforming growth factor beta receptors in dermal fibroblasts in skin sections from patients with localized scleroderma","volume":"44","author":"Kubo","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaut.2010.09.004","article-title":"Activation of the Activin A-ALK-Smad pathway in systemic sclerosis","volume":"36","author":"Takagi","year":"2011","journal-title":"J Autoimmun"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1073\/pnas.062010399","article-title":"Deficient Smad7 expression: a putative molecular defect in scleroderma","volume":"99","author":"Dong","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"19738","DOI":"10.1074\/jbc.272.32.19738","article-title":"Sp1 is required for the early response of alpha2(I) collagen to transforming growth factor-beta1","volume":"272","author":"Greenwel","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1165\/ajrcmb.26.2.4666","article-title":"Transforming growth factor-beta stabilizes elastin mRNA by a pathway requiring active Smads, protein kinase C-delta, and p38","volume":"26","author":"Kucich","year":"2002","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"16709","DOI":"10.1074\/jbc.275.22.16709","article-title":"Induction of platelet-derived growth factor B-chain expression by transforming growth factor-beta involves transactivation by Smads","volume":"275","author":"Taylor","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB77|cit77","first-page":"72","article-title":"Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathway","volume":"43","author":"You","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"36400","DOI":"10.1074\/jbc.M002131200","article-title":"Transforming growth factor-beta up-regulates the beta 5 integrin subunit expression via Sp1 and Smad signaling","volume":"275","author":"Lai","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1101\/gad.9.15.1831","article-title":"Kip\/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta","volume":"9","author":"Reynisdottir","year":"1995","journal-title":"Genes Dev"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/jcp.1041560108","article-title":"Transforming growth factor beta 1-mediated inhibition of smooth muscle cell proliferation is associated with a late G1 cell cycle arrest","volume":"156","author":"Reddy","year":"1993","journal-title":"J Cell Physiol"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1091\/mbc.E02-02-0063","article-title":"Functional heterogeneity of bone morphogenetic protein receptor-II mutants found in patients with primary pulmonary hypertension","volume":"13","author":"Nishihara","year":"2002","journal-title":"Mol Biol Cell"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.coph.2009.02.007","article-title":"TGF-beta and BMPR-II pharmacology - implications for pulmonary vascular diseases","volume":"9","author":"Upton","year":"2009","journal-title":"Curr opin pharmacol"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1359-6101(96)00048-2","article-title":"Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity","volume":"8","author":"Pepper","year":"1997","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1111\/j.1742-1241.2011.02726.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.2741\/3573","article-title":"Transforming growth factor-beta signaling and tumor angiogenesis","volume":"14","author":"Pardali","year":"2009","journal-title":"Front biosci"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2011.02726.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2011.02726.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T14:54:10Z","timestamp":1712588050000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2011.02726.x"}},"subtitle":["Transforming growth factor signalling"],"short-title":[],"issued":{"date-parts":[[2011,7,7]]},"references-count":84,"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2011.02726.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7,7]]}}}